Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation.
about
Prognostic value of HIFs expression in head and neck cancer: a systematic reviewAssociation of drug transporter expression with mortality and progression-free survival in stage IV head and neck squamous cell carcinomaCyclophilin B expression is associated with in vitro radioresistance and clinical outcome after radiotherapy.MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy.Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research SubcommitteeBAY 87-2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenograftsThe small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosisDoes primary tumour volumetry performed early in the course of definitive concomitant chemoradiotherapy for head and neck squamous cell carcinoma improve prediction of primary site outcome?Lack of association between expression of MRP2 and early relapse of colorectal cancer in patients receiving FOLFOX-4 chemotherapy.Is human papillomavirus involved in laryngeal neuroendocrine carcinoma?MRP2 (ABCC2, cMOAT) expression in nuclear envelope of primary fallopian tube cancer cells is a new unfavorable prognostic factor.Cordycepin enhances cisplatin apoptotic effect through caspase/MAPK pathways in human head and neck tumor cells.Hypoxic repression of pyruvate dehydrogenase activity is necessary for metabolic reprogramming and growth of model tumours.No evidence for desmocollin 3 to serve as a prognostic marker in primary radiotherapy of head and neck cancer.Clinical implications of hypoxia biomarker expression in head and neck squamous cell carcinoma: a systematic review.SERPINB2 down-regulation contributes to chemoresistance in head and neck cancer.Apoptotic effect of cisplatin and cordycepin on OC3 human oral cancer cells.Prognostic value of HIF-1α expression during fractionated irradiation.Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma.Prognostic significance of HIF-1a, CA-IX, and OPN in T1-T2 laryngeal carcinoma treated with radiotherapy.Use of cyclin D1 in conjunction with human papillomavirus status to predict outcome in oropharyngeal cancer.Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma.HPV status of oropharyngeal cancer by combination HPV DNA/p16 testing: biological relevance of discordant results.Deceptive argumentation against diagnostic microdosing of anticancer drugs
P2860
Q27692688-7993FEF7-3C60-4A2E-8849-CC6C804D54C5Q28543497-D620191D-AE3B-46EE-BD5F-62543D519434Q30428813-E7B570DD-F497-4CCF-8A35-C185E1C8D9ECQ33651005-1EDA34BD-3540-4F6C-AD45-29BA254A6895Q34160540-0A621121-0CE7-4DDC-B2C2-71FD07A45993Q34672437-4B2CC13E-5B7F-4646-9E15-B7C6D9AB1B25Q34745747-3BE43073-A2BC-4056-B3FA-159C435EBC2EQ36324844-0F5280D6-D356-4A7D-A9A2-E8ADA9261AE1Q36403439-B7506E87-3662-4145-B744-9534F6EDD39EQ36578125-A12979A8-60C0-4D8C-9EC2-2A9613ED79D7Q36601950-AB67B7A0-E967-45AB-8BF6-1DB123ACE587Q37057370-A7008E90-21F0-419A-A399-9041668F3203Q37157453-0723FB9E-EE47-41A4-AA73-17035971B2BFQ38258636-BE166A8A-294A-43DF-870D-B45AB01C8FC4Q38445971-82EBBE16-10AF-4C94-AE30-A1577E94B681Q39153932-F5E316DE-5A35-4EBF-9749-5EB23B99BF29Q39173239-8D50D26B-C81B-4B0C-B67B-E037971B443AQ39262531-0ADC62E0-5849-4679-8DBE-E02645394E8BQ39663607-1EB41590-79BB-4850-A061-6F66794BA621Q43543147-562E82DA-A343-4BF2-8241-859FB45B62BCQ43689874-31AAC98E-3939-49ED-949B-BDD716D03111Q53064658-34D1E904-36CC-49B7-9C8A-2234E491F0F2Q54467947-B20F488A-1260-490F-B114-E97E3B9A0821Q56832226-9CD951FF-DCDF-4E8D-955A-7793263D4245
P2860
Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Molecular markers predict outc ...... isplatin-based chemoradiation.
@en
Molecular markers predict outc ...... isplatin-based chemoradiation.
@nl
type
label
Molecular markers predict outc ...... isplatin-based chemoradiation.
@en
Molecular markers predict outc ...... isplatin-based chemoradiation.
@nl
prefLabel
Molecular markers predict outc ...... isplatin-based chemoradiation.
@en
Molecular markers predict outc ...... isplatin-based chemoradiation.
@nl
P2093
P2860
P356
P1476
Molecular markers predict outc ...... cisplatin-based chemoradiation
@en
P2093
Adrian C Begg
Alfons J M Balm
Coen R N Rasch
Ed Schuuring
Guido B van den Broek
Jacqueline E van der Wal
Lorian Menkema
Maarten Wildeman
Marie-Louise F van Velthuysen
Michiel W M van den Brekel
P2860
P304
P356
10.1002/IJC.24254
P577
2009-06-01T00:00:00Z